Monthly Archives: June 2021

FDA must ban sales of illegal regenerative medicine products

The Food and Drug Administration has promised that after May 31, 2021, the agency will broadly enforce requirements that developers of regenerative medicine products – therapies intended to repair or replace damaged cells, tissues and organs – follow relevant approval rules for new drugs , medical devices and biological products. …

Read More »